Skip to main content
Top
Published in: Journal of Translational Medicine 1/2017

Open Access 01-12-2017 | Research

Detecting the tipping points in a three-state model of complex diseases by temporal differential networks

Authors: Pei Chen, Yongjun Li, Xiaoping Liu, Rui Liu, Luonan Chen

Published in: Journal of Translational Medicine | Issue 1/2017

Login to get access

Abstract

Background

The progression of complex diseases, such as diabetes and cancer, is generally a nonlinear process with three stages, i.e., normal state, pre-disease state, and disease state, where the pre-disease state is a critical state or tipping point immediately preceding the disease state. Traditional biomarkers aim to identify a disease state by exploiting the information of differential expressions for the observed molecules, but may fail to detect a pre-disease state because there are generally little significant differences between the normal and pre-disease states. Thus, it is challenging to signal the pre-disease state, which actually implies the disease prediction.

Methods

In this work, by exploiting the information of differential associations among the observed molecules between the normal and pre-disease states, we propose a temporal differential network based computational method to accurately signal the pre-disease state or predict the occurrence of severe disease. The theoretical foundation of this work is the quantification of the critical state using dynamical network biomarkers.

Results

Considering that there is one stationary Markov process before reaching the tipping point, a novel index, inconsistency score (I-score), is proposed to quantitatively measure the change of the stationary processes from the normal state so as to detect the onset of pre-disease state. In other words, a drastic increase of I-score implies the high inconsistency with the preceding stable state and thus signals the upcoming critical transition. This approach is applied to the simulated and real datasets of three diseases, which demonstrates the effectiveness of our method for predicting the deterioration into disease states. Both functional analysis and pathway enrichment also validate the computational results from the perspectives of both molecules and networks.

Conclusions

At the molecular network level, this method provides a computational way of unravelling the underlying mechanism of the dynamical progression when a biological system is near the tipping point, and thus detecting the early-warning signal of the imminent critical transition, which may help to achieve timely intervention. Moreover, the rewiring of differential networks effectively extracts discriminatively interpretable features, and systematically demonstrates the dynamical change of a biological system.
Appendix
Available only for authorised users
Literature
1.
go back to reference Liu R, Wang X, Aihara K, Chen L. Early diagnosis of complex diseases by molecular biomarkers, network biomarkers, and dynamical network biomarkers. Med Res Rev. 2014;34(3):455–78.PubMedCrossRef Liu R, Wang X, Aihara K, Chen L. Early diagnosis of complex diseases by molecular biomarkers, network biomarkers, and dynamical network biomarkers. Med Res Rev. 2014;34(3):455–78.PubMedCrossRef
2.
go back to reference Scheffer M, Bascompte J, Brock WA, Brovkin V, Carpenter SR, Dakos V, et al. Early-warning signals for critical transitions. Nature. 2009;461(7260):53–9.PubMedCrossRef Scheffer M, Bascompte J, Brock WA, Brovkin V, Carpenter SR, Dakos V, et al. Early-warning signals for critical transitions. Nature. 2009;461(7260):53–9.PubMedCrossRef
3.
go back to reference He D, Liu ZP, Honda M, Kaneko S, Chen L. Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma. J Mol Cell Biol. 2012;4(3):140–52.PubMedCrossRef He D, Liu ZP, Honda M, Kaneko S, Chen L. Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma. J Mol Cell Biol. 2012;4(3):140–52.PubMedCrossRef
4.
go back to reference Tan Z, Liu R, Zheng L, Hao S, Fu C, Li Z, et al. Cerebrospinal fluid protein dynamic driver network: at the crossroads of brain tumorigenesis. Methods. 2015;83:36–43.PubMedCrossRef Tan Z, Liu R, Zheng L, Hao S, Fu C, Li Z, et al. Cerebrospinal fluid protein dynamic driver network: at the crossroads of brain tumorigenesis. Methods. 2015;83:36–43.PubMedCrossRef
5.
go back to reference Achiron A, Grotto I, Balicer R, Magalashvili D, Feldman A, Gurevich M. Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosis. Neurobiol Dis. 2010;38(2):201–9.PubMedCrossRef Achiron A, Grotto I, Balicer R, Magalashvili D, Feldman A, Gurevich M. Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosis. Neurobiol Dis. 2010;38(2):201–9.PubMedCrossRef
6.
go back to reference Chen L, Liu R, Liu ZP, Li M, Aihara K. Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci Rep. 2012;2:342. Chen L, Liu R, Liu ZP, Li M, Aihara K. Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci Rep. 2012;2:342.
7.
go back to reference Liu R, Aihara K, Chen L. Dynamical network biomarkers for identifying critical transitions and their driving networks of biologic processes. Quant Biol. 2013;1(2):105–14.CrossRef Liu R, Aihara K, Chen L. Dynamical network biomarkers for identifying critical transitions and their driving networks of biologic processes. Quant Biol. 2013;1(2):105–14.CrossRef
8.
go back to reference Litt B, Esteller R, Echauz J, Alessandro MD, Shor R, Henry T, et al. Epileptic seizures may begin hours in advance of clinical onset: a report of five patients. Neuron. 2001;30(1):51–64.PubMedCrossRef Litt B, Esteller R, Echauz J, Alessandro MD, Shor R, Henry T, et al. Epileptic seizures may begin hours in advance of clinical onset: a report of five patients. Neuron. 2001;30(1):51–64.PubMedCrossRef
9.
go back to reference Venegas JG, Winkler T, Musch G, Melo MF, Layfield D, Tgavalekos N, et al. Self-organized patchiness in asthma as a prelude to catastrophic shifts. Nature. 2005;434(7034):777–82.PubMedCrossRef Venegas JG, Winkler T, Musch G, Melo MF, Layfield D, Tgavalekos N, et al. Self-organized patchiness in asthma as a prelude to catastrophic shifts. Nature. 2005;434(7034):777–82.PubMedCrossRef
10.
go back to reference McSharry PE, Smith LA, Tarassenko L. Prediction of epileptic seizures: are nonlinear methods relevant? Nat Med. 2003;9(3):241–2.PubMedCrossRef McSharry PE, Smith LA, Tarassenko L. Prediction of epileptic seizures: are nonlinear methods relevant? Nat Med. 2003;9(3):241–2.PubMedCrossRef
11.
go back to reference Roberto PB, Eliseo G, Josef C. Transition models for change-point estimation in logistic regression. Statist Med. 2003;22:1141–62.CrossRef Roberto PB, Eliseo G, Josef C. Transition models for change-point estimation in logistic regression. Statist Med. 2003;22:1141–62.CrossRef
12.
go back to reference Paek SH, Chung HT, Jeong SS, Park C, Kim C, Kim JE, et al. Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma. Cancer. 2005;104(3):580–90.PubMedCrossRef Paek SH, Chung HT, Jeong SS, Park C, Kim C, Kim JE, et al. Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma. Cancer. 2005;104(3):580–90.PubMedCrossRef
13.
go back to reference Liu JK, Rovit RL, Couldwell WT. Pituitary apoplexy. Semin Neurosurg. 2001;12(03):315–20.CrossRef Liu JK, Rovit RL, Couldwell WT. Pituitary apoplexy. Semin Neurosurg. 2001;12(03):315–20.CrossRef
15.
go back to reference Liu R, Li M, Liu ZP, Aihara K, Chen L. Identifying critical transitions and their leading biomolecular networks in complex diseases. Sci Rep. 2012;2:813.PubMedPubMedCentralCrossRef Liu R, Li M, Liu ZP, Aihara K, Chen L. Identifying critical transitions and their leading biomolecular networks in complex diseases. Sci Rep. 2012;2:813.PubMedPubMedCentralCrossRef
16.
go back to reference Liu R, Yu X, Liu X, Xu D, Aihara K, Chen L. Identifying critical transitions of complex diseases based on a single sample. Bioinformatics. 2014;30(11):1579–86.PubMedCrossRef Liu R, Yu X, Liu X, Xu D, Aihara K, Chen L. Identifying critical transitions of complex diseases based on a single sample. Bioinformatics. 2014;30(11):1579–86.PubMedCrossRef
17.
go back to reference Li M, Zeng T, Liu R, Chen L. Detecting tissue-specific early warning signals for complex diseases based on dynamical network biomarkers: study of type 2 diabetes by cross-tissue analysis. Brief Bioinform. 2014;15(2):229–43.PubMedCrossRef Li M, Zeng T, Liu R, Chen L. Detecting tissue-specific early warning signals for complex diseases based on dynamical network biomarkers: study of type 2 diabetes by cross-tissue analysis. Brief Bioinform. 2014;15(2):229–43.PubMedCrossRef
18.
go back to reference Chen P, Liu R, Chen L, Aihara K. Identifying critical differentiation state of MCF-7 cells for breast cancer by dynamical network biomarkers. Front Genet. 2015;6:252.PubMedPubMedCentralCrossRef Chen P, Liu R, Chen L, Aihara K. Identifying critical differentiation state of MCF-7 cells for breast cancer by dynamical network biomarkers. Front Genet. 2015;6:252.PubMedPubMedCentralCrossRef
19.
go back to reference Liu R, Chen P, Aihara K, Chen L. Identifying early-warning signals of critical transitions with strong noise by dynamical network markers. Sci Rep. 2015;5:17501. Liu R, Chen P, Aihara K, Chen L. Identifying early-warning signals of critical transitions with strong noise by dynamical network markers. Sci Rep. 2015;5:17501.
20.
go back to reference Liu X, Liu R, Zhao XM, Chen L. Detecting early-warning signals of type 1 diabetes and its leading biomolecular networks by dynamical network biomarkers. BMC Med Genom. 2013;6(Suppl 2):S8.CrossRef Liu X, Liu R, Zhao XM, Chen L. Detecting early-warning signals of type 1 diabetes and its leading biomolecular networks by dynamical network biomarkers. BMC Med Genom. 2013;6(Suppl 2):S8.CrossRef
21.
go back to reference Chen P, Liu R, Li Y, Chen L. Detecting critical state before phase transition of complex biological systems by hidden Markov model. Bioinformatics. 2016;32(14):2143–50.PubMedCrossRef Chen P, Liu R, Li Y, Chen L. Detecting critical state before phase transition of complex biological systems by hidden Markov model. Bioinformatics. 2016;32(14):2143–50.PubMedCrossRef
22.
go back to reference Mojtahedi M, Skupin A, Zhou J, Castano IG, Leong-Quong RYY, et al. Cell fate decision as high-dimensional critical state transition. PLoS Biol. 2016;14(12):e2000640.PubMedPubMedCentralCrossRef Mojtahedi M, Skupin A, Zhou J, Castano IG, Leong-Quong RYY, et al. Cell fate decision as high-dimensional critical state transition. PLoS Biol. 2016;14(12):e2000640.PubMedPubMedCentralCrossRef
23.
go back to reference Richard A, Boullu L, Herbach U, Bonnafoux A, Morin V, et al. Single-cell-based analysis highlights a surge in cell-to-cell molecular variability preceding irreversible commitment in a differentiation process. PLoS Biol. 2016;14(12):e1002585.PubMedPubMedCentralCrossRef Richard A, Boullu L, Herbach U, Bonnafoux A, Morin V, et al. Single-cell-based analysis highlights a surge in cell-to-cell molecular variability preceding irreversible commitment in a differentiation process. PLoS Biol. 2016;14(12):e1002585.PubMedPubMedCentralCrossRef
25.
go back to reference Chen P, Li Y. The decrease of consistence probability: at the crossroad of catastrophic transition of a biological system. BMC Syst Biol. 2016;10(2):50.PubMedPubMedCentralCrossRef Chen P, Li Y. The decrease of consistence probability: at the crossroad of catastrophic transition of a biological system. BMC Syst Biol. 2016;10(2):50.PubMedPubMedCentralCrossRef
26.
go back to reference Gilmore R. Catastrophe theory for scientists and engineers. New York: Dover Publications; 1993. Gilmore R. Catastrophe theory for scientists and engineers. New York: Dover Publications; 1993.
27.
go back to reference Schadt EE. Molecular networks as sensors and drivers of common human diseases. Nature. 2009;461(7261):218–23.PubMedCrossRef Schadt EE. Molecular networks as sensors and drivers of common human diseases. Nature. 2009;461(7261):218–23.PubMedCrossRef
28.
go back to reference Liu X, Liu ZP, Zhao XM, Chen L. Identifying disease genes and module biomarkers by differential interactions. J Am Med Inform Assoc. 2012;19(2):241–8.PubMedCrossRef Liu X, Liu ZP, Zhao XM, Chen L. Identifying disease genes and module biomarkers by differential interactions. J Am Med Inform Assoc. 2012;19(2):241–8.PubMedCrossRef
29.
go back to reference Chen L, Wang RS, Zhang XS. Biomolecular networks: methods and applications in systems biology. Hoboken: Wiley; 2009.CrossRef Chen L, Wang RS, Zhang XS. Biomolecular networks: methods and applications in systems biology. Hoboken: Wiley; 2009.CrossRef
30.
go back to reference Sciuto AM, Phillips CS, Orzolek LD, Hege AI, Moran TS, Dillman JF. Genomic analysis of murine pulmonary tissue following carbonyl chloride inhalation. Chem Res Toxicol. 2005;18(11):1654–60.PubMedCrossRef Sciuto AM, Phillips CS, Orzolek LD, Hege AI, Moran TS, Dillman JF. Genomic analysis of murine pulmonary tissue following carbonyl chloride inhalation. Chem Res Toxicol. 2005;18(11):1654–60.PubMedCrossRef
31.
go back to reference Fang Y, Choi D, Searles RP, Mathers WD. A time course microarray study of gene expression in the mouse lacrimal gland after acute corneal trauma. Invest Ophthalmol Vis Sci. 2005;46(2):461–9.PubMedCrossRef Fang Y, Choi D, Searles RP, Mathers WD. A time course microarray study of gene expression in the mouse lacrimal gland after acute corneal trauma. Invest Ophthalmol Vis Sci. 2005;46(2):461–9.PubMedCrossRef
32.
go back to reference Saeki Y, et al. Ligand-specific sequential regulation of transcription factors for differentiation of MCF-7 cells. BMC Genom. 2009;20:545–52.CrossRef Saeki Y, et al. Ligand-specific sequential regulation of transcription factors for differentiation of MCF-7 cells. BMC Genom. 2009;20:545–52.CrossRef
33.
go back to reference Schneider W, Diller W. Phosgene, in Ullmann’s Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH; 2000. p. 411–4. Schneider W, Diller W. Phosgene, in Ullmann’s Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH; 2000. p. 411–4.
34.
go back to reference Wang P, Ye XL, Liu R, Chen HL, Liang X, Li WL, et al. Mechanism of acute lung injury due to phosgene exposition and its protection by cafeic acid phenethyl ester in the rat. Exp Toxicol Pathol. 2013;65(3):311–8.PubMedCrossRef Wang P, Ye XL, Liu R, Chen HL, Liang X, Li WL, et al. Mechanism of acute lung injury due to phosgene exposition and its protection by cafeic acid phenethyl ester in the rat. Exp Toxicol Pathol. 2013;65(3):311–8.PubMedCrossRef
35.
go back to reference Herlaar E, Brown Z. p38 MAPK signalling cascades in inflammatory disease. Mol Med Today. 1999;5(10):439–47.PubMedCrossRef Herlaar E, Brown Z. p38 MAPK signalling cascades in inflammatory disease. Mol Med Today. 1999;5(10):439–47.PubMedCrossRef
Metadata
Title
Detecting the tipping points in a three-state model of complex diseases by temporal differential networks
Authors
Pei Chen
Yongjun Li
Xiaoping Liu
Rui Liu
Luonan Chen
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2017
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-017-1320-7

Other articles of this Issue 1/2017

Journal of Translational Medicine 1/2017 Go to the issue